By Research Area
Hot products 
-
Rabbit Anti-CAMK2A Recombinant Antibody (BA0032) (CBMAB-0137CQ)
-
Mouse Anti-GZMA Recombinant Antibody (CBLG1-2197) (CBMAB-G5901-LY)
-
Mouse Anti-BCL6 Recombinant Antibody (CBYY-0442) (CBMAB-0445-YY)
-
Mouse Anti-BMI1 Recombinant Antibody (CBYC-P026) (CBMAB-P0108-YC)
-
Mouse Anti-EIF4G1 Recombinant Antibody (2A9) (CBMAB-A2544-LY)
-
Mouse Anti-CCN2 Recombinant Antibody (CBFYC-2383) (CBMAB-C2456-FY)
-
Rabbit Anti-CCL5 Recombinant Antibody (R0437) (CBMAB-R0437-CN)
-
Mouse Anti-CASQ1 Recombinant Antibody (CBFYC-0863) (CBMAB-C0918-FY)
-
Mouse Anti-8-oxoguanine Recombinant Antibody (V2-7719) (CBMAB-1898CQ)
-
Mouse Anti-DLG1 Monolconal Antibody (4F3) (CBMAB-0225-CN)
-
Rabbit Anti-BRCA2 Recombinant Antibody (D9S6V) (CBMAB-CP0017-LY)
-
Mouse Anti-DES Monoclonal Antibody (440) (CBMAB-AP1857LY)
-
Mouse Anti-ARID1B Recombinant Antibody (KMN1) (CBMAB-A3546-YC)
-
Mouse Anti-CARTPT Recombinant Antibody (113612) (CBMAB-C2450-LY)
-
Mouse Anti-FLI1 Recombinant Antibody (CBXF-0733) (CBMAB-F0435-CQ)
-
Rabbit Anti-ENO2 Recombinant Antibody (BA0013) (CBMAB-0272CQ)
-
Mouse Anti-dsRNA Recombinant Antibody (2) (CBMAB-D1807-YC)
-
Mouse Anti-DMD Recombinant Antibody (D1190) (CBMAB-D1190-YC)
-
Mouse Anti-ADIPOR1 Recombinant Antibody (V2-179982) (CBMAB-A1368-YC)
-
Mouse Anti-GFAP Recombinant Antibody (24) (CBMAB-G2927-LY)
Breast Cancer Research
Breast cancer is a common malignant tumor that starts in the breast tissue, predominantly impacting women but occasionally occurring in men. As the most common cancer worldwide among women, it accounts for approximately 1/4 of cancer cases in females. Key risk factors include age, genetic mutations (BRCA1/2), lifestyle factors, hormonal effects, and family history. Early detection through mammograms and clinical exams significantly improves outcomes, with 5-year survival rates exceeding 90% for localized cases. Modern treatments range from surgery (lumpectomy/mastectomy) to advanced therapies like targeted drugs (e.g., HER2 inhibitors) and immunotherapy, often combined with chemotherapy, radiation, or hormone therapy based on tumor characteristics. Ongoing research focuses on precision medicine and early biomarkers to enhance prevention and personalized care.
Creative Biolabs is dedicated to developing high-quality, specialized antibodies for breast cancer research. Our antibodies are meticulously optimized to ensure exceptional specificity and sensitivity. Explore our comprehensive antibody portfolio to advance your breast cancer diagnostic and therapeutic development efforts.
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Loading...
Compare
